Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.

Clinical trial NCT04395170 · UNKNOWN

Trial details

NCT number: NCT04395170
Sponsor: Lifefactors Zona Franca, SAS
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Coronavirus Disease 2019 (COVID-19)

Start date: 2020-09-01
Primary completion: 2020-12-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.